Philip P. Connell to Neoplasms
This is a "connection" page, showing publications Philip P. Connell has written about Neoplasms.
Connection Strength
0.877
-
Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy? ChemMedChem. 2016 11 21; 11(22):2468-2473.
Score: 0.190
-
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res. 2014 Jul 01; 74(13):3546-55.
Score: 0.160
-
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy. Sci Transl Med. 2014 Mar 26; 6(229):229ra42.
Score: 0.159
-
A downside to apoptosis in cancer therapy? Nat Med. 2011 Jul 07; 17(7):780-2.
Score: 0.132
-
Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 2009 Jan 15; 69(2):383-92.
Score: 0.111
-
Relevance and irrelevance of DNA damage response to radiotherapy. DNA Repair (Amst). 2004 Aug-Sep; 3(8-9):1245-51.
Score: 0.082
-
RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. Nucleic Acids Res. 2015 Mar 31; 43(6):3180-96.
Score: 0.043